These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2745148)

  • 1. [Hepatitis B associated membraneous glomerulonephritis: healing following drug-induced reactivation of hepatitis].
    Tönz O; Ramelli GP; Gebbers JO
    Helv Paediatr Acta; 1989 Jun; 43(5-6):539-47. PubMed ID: 2745148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinico-pathologic features of hepatitis B virus-associated glomerulonephritis.
    Lai KN; Lai FM; Chan KW; Chow CB; Tong KL; Vallance-Owen J
    Q J Med; 1987 Apr; 63(240):323-33. PubMed ID: 3685245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of hepatitis B virus infection in two patients: immunofluorescence studies of liver tissue.
    Villa E; Theodossi A; Portmann B; Eddleston AL; Williams R
    Gastroenterology; 1981 May; 80(5 pt 1):1048-53. PubMed ID: 7009312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus-related nephropathy and lupus nephritis: morphologic similarities of two clinical entities.
    Lai FM; To KF; Wang AY; Choi PC; Szeto CC; Li PK; Leung CB; Lai KN
    Mod Pathol; 2000 Feb; 13(2):166-72. PubMed ID: 10697274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membranous nephropathy associated with hepatitis B in Spanish children.
    Peña A; Débora MJ; Melgosa M; Luz Picazo M; Navarro M
    Clin Nephrol; 2001 Jan; 55(1):25-30. PubMed ID: 11200864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential localization of s and e antigens in hepatitis B virus-associated glomerulonephritis.
    Ohba S; Kimura K; Mise N; Konno Y; Suzuki N; Miyashita K; Tojo A; Hirata Y; Uehara Y; Atarashi K; Goto A; Omata M
    Clin Nephrol; 1997 Jul; 48(1):44-7. PubMed ID: 9247778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
    Ozdamar SO; Gucer S; Tinaztepe K
    Pediatr Nephrol; 2003 Jan; 18(1):23-8. PubMed ID: 12488986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis.
    Koo YX; Tan DS; Tan BH; Quek R; Tao M; Lim ST
    J Clin Oncol; 2009 May; 27(15):2570-1; author reply 2571-2. PubMed ID: 19364951
    [No Abstract]   [Full Text] [Related]  

  • 9. Membranous glomerulonephritis associated with hepatitis B antigen in children: a comparison with idiopathic membranous glomerulonephritis.
    Yoshikawa N; Ito H; Yamada Y; Hashimoto H; Katayama Y; Matsuyama S; Hasegawa O; Okada S; Hajikano H; Yoshizawa H
    Clin Nephrol; 1985 Jan; 23(1):28-34. PubMed ID: 3978879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
    J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of membranous proliferative glomerulonephritis type III (Burkholder) with the deposition of both HBeAg and HBsAg.
    Amemiya S; Ito H; Kato K; Sakaguchi H; Hasegawa O; Hajikano H
    Int J Pediatr Nephrol; 1983 Dec; 4(4):267-73. PubMed ID: 6363317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids.
    Kim TW; Kim MN; Kwon JW; Kim KM; Kim SH; Kim W; Park HW; Chang YS; Cho SH; Min KU; Kim YY
    Respirology; 2010 Oct; 15(7):1092-7. PubMed ID: 20630033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Membranous glomerulonephritis caused by HBs (Australia) antigen-antibody complexes].
    Nagy J; Par A; Bajtai G; Ambus M; Deak G
    Morphol Igazsagugyi Orv Sz; 1977 Feb; 17(1):38-42. PubMed ID: 857150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy.
    Tseng TC; Liu CJ; Hsieh SC; Chen PJ; Lai MY; Chen DS; Kao JH
    Dig Liver Dis; 2009 Apr; 41(4):322-3. PubMed ID: 18848814
    [No Abstract]   [Full Text] [Related]  

  • 15. Crescentic glomerulonephritis related to hepatitis B virus.
    Lai FM; Li PK; Suen MW; Lui SF; Lai KN
    Mod Pathol; 1992 May; 5(3):262-7. PubMed ID: 1495931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of membranous glomerulonephritis in which positive to negative change of hepatitis B e antigen in glomeruli was observed.
    Nagata K; Fujita M; Aoyama R; Miyakawa Y; Yoshizawa K; Mayumi M
    Int J Pediatr Nephrol; 1981 Jun; 2(2):103-8. PubMed ID: 7042619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glomerular nephropathies and B virus: apropos of 4 cases in adults, with an immunofluorescence study and review of the literature].
    Poitrine A; Delfraissy JF; Brunaud MD; Brivet F; Pillot J; Dormont J; Chaput JC
    Gastroenterol Clin Biol; 1983; 7(6-7):610-7. PubMed ID: 6347798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic active hepatitis and membraneous glomerulonephritis.
    Cogan MG; Graber ML; Connor DG
    Am J Gastroenterol; 1977 Oct; 68(4):386-91. PubMed ID: 605896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
    Picardi M; Pane F; Quintarelli C; De Renzo A; Del Giudice A; De Divitiis B; Persico M; Ciancia R; Salvatore F; Rotoli B
    Haematologica; 2003 Nov; 88(11):1296-303. PubMed ID: 14607759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients.
    Markovic S; Drozina G; Vovk M; Fidler-Jenko M
    Hepatogastroenterology; 1999; 46(29):2925-30. PubMed ID: 10576374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.